Skip to main content
Caplight Logo









Hubly Surgical

Hubly Surgical

Private
Lisle, IllinoisHealthcare & Life Scienceshttps://hublysurgical.com/

Last Round

Seed

Jul 21, 2023

Total Funding Raised

$4.52M

Company Overview

Hubly Surgical is a medical device company that develops and manufactures battery-powered cranial drill systems designed to make bedside intracranial access safer and more efficient.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

neurosurgical drillcranial drillneurosurgerymedical deviceexternal ventricular drainEVDbedside neurosurgeryplunge preventionsurgical safetyneuro-critical carecranial accesssmart drillsurgical roboticsmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hubly Surgical Comparables

Compare Hubly Surgical with similar companies based on industry and business-model similarity.

Hubly Surgical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Phasor Health
92%
Surgify Medical
82%
evonos
81%

Hubly Surgical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 21, 2023
AcceleratorJul 29, 2022
SeedDec 22, 2021
AcceleratorSep 1, 2020
Pre SeedJun 9, 2020

Key People

Founding team and executive leadership

Mark Fisher

COO And Corporate Board Member

Executive Team

Hubly Surgical Investors

Notable investors and investment history

Hubly Surgical investors
InvestorRounds
757 AccelerateAccelerator, Seed
HalcyonSeed
Alchemist AcceleratorPre Seed, Accelerator
First FundSeed
OCA VenturesSeed
Golden SeedsSeed
National Science FoundationPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 18, 2025

    Secured Innovative Technology contract with Vizient, Inc.

  • Jul 21, 2023

    Raised $3M from OCA Ventures and other investors.

Hubly Surgical Filings

Explore SEC and related filing metadata, where available.

Hubly Surgical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Hubly Surgical's valuation, stock price, and market status.

Is Hubly Surgical a public or private company?

Hubly Surgical is a private company.

What is the current stock price of Hubly Surgical?

Hubly Surgical is a private company with no public stock price. No recent secondary market data is available.

How much is Hubly Surgical worth (valuation)?

Valuation information for Hubly Surgical is not publicly available.

Can I buy Hubly Surgical stock?

Hubly Surgical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Hubly Surgical's last funding round?

Hubly Surgical's most recent funding round was Seed on July 21, 2023.

Who are the main investors in Hubly Surgical?

Key investors in Hubly Surgical include First Fund.

Will Hubly Surgical IPO soon?

No public IPO plans have been announced for Hubly Surgical.

How can I track Hubly Surgical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hubly Surgical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLisle, Illinois
Employee Range19
Year Founded2019
Last FundingJul 21, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?